Recurrent grade 3B follicular lymphoma
Clinical trials for Recurrent grade 3B follicular lymphoma explained in plain language.
Never miss a new study
Get alerted when new Recurrent grade 3B follicular lymphoma trials appear
Sign up with your email to follow new studies for Recurrent grade 3B follicular lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug boosts Cancer-Killing cells in lymphoma trial
Disease control CompletedThis early-phase trial tests whether adding an experimental drug called NKTR-255 to standard CAR-T cell therapy can improve outcomes for people with large B-cell lymphoma that has returned or not responded to treatment. The study involves 27 adults and focuses on safety and how w…
Matched conditions: RECURRENT GRADE 3B FOLLICULAR LYMPHOMA
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
New drug cocktail shows promise for Tough-to-Treat lymphoma
Disease control CompletedThis early-stage trial tested a combination of two drugs, lenalidomide and blinatumomab, in 35 adults with non-Hodgkin lymphoma that had come back or stopped responding to treatment. The main goal was to find the safest dose and understand side effects. Researchers also looked at…
Matched conditions: RECURRENT GRADE 3B FOLLICULAR LYMPHOMA
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC